Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030

SA Al-Busafi, A Alwassief - Vaccines, 2024 - mdpi.com
Annually, more than 1.5 million preventable new hepatitis B (HBV) infections continue to
occur, with an estimated global burden of 296 million individuals living with chronic hepatitis …

Hepatitis B virus genotype surveillance in Canadian blood donors and a referred patient population, 2016–2021

C Osiowy, E Giles, CF Lowe, N Matic… - Vox …, 2024 - Wiley Online Library
Abstract Background and Objectives Hepatitis B virus (HBV) genotypes (A–H) have a distinct
geographic distribution and are highly associated with the country of birth. Canada has …

Comparison of the effectiveness four years after Homo/Hetero prime-boost with 10 μg HP and 20 μg CHO recombinant hepatitis B vaccine at 1 and 6 months in …

Z Yin, T Wen, C Fu, J Li, Q Fang, X Gong… - Frontiers in …, 2024 - frontiersin.org
Introduction Limited data were available on the effectivenessfour years after Homo or Hetero
prime-boost with 10 μg Hansenulapolymorpha recombinant hepatitis B vaccine (HepB-HP) …

Timing of Hepatitis B Vaccine Birth Dose in Exposed Newborns, Southwest Ethiopia: A Cross-Sectional Study

M Demissie, HA Weldekidan, Y Yosef… - SAGE Open …, 2023 - journals.sagepub.com
Introduction Hepatitis B virus disease is a global acute and chronic communicable disease.
Mother-to-child transmission is the reason for high carrier rates. Unvaccinated newborns …